Dorthe Lundsgaard

1.2k total citations
23 papers, 1.0k citations indexed

About

Dorthe Lundsgaard is a scholar working on Immunology, Genetics and Rheumatology. According to data from OpenAlex, Dorthe Lundsgaard has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 8 papers in Genetics and 5 papers in Rheumatology. Recurrent topics in Dorthe Lundsgaard's work include Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (9 papers) and Diabetes and associated disorders (6 papers). Dorthe Lundsgaard is often cited by papers focused on Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (9 papers) and Diabetes and associated disorders (6 papers). Dorthe Lundsgaard collaborates with scholars based in Denmark, United States and Australia. Dorthe Lundsgaard's co-authors include Kresten Skak, Klaus Stensgaard Frederiksen, Claus Johansen, Rasmus Boye Kjellerup, P.A. Usher, Knud Kragballe, Lars Iversen, Helle Markholst, Birte K. Skrumsager and Ian D. Davis and has published in prestigious journals such as Diabetes, Clinical Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Dorthe Lundsgaard

23 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorthe Lundsgaard Denmark 12 824 335 158 123 97 23 1.0k
Kresten Skak Denmark 18 839 1.0× 517 1.5× 135 0.9× 143 1.2× 38 0.4× 37 1.2k
Gabriella Rodolico Italy 7 518 0.6× 146 0.4× 60 0.4× 45 0.4× 39 0.4× 10 772
Kamruz Darabi United States 8 447 0.5× 218 0.7× 172 1.1× 40 0.3× 47 0.5× 13 749
Christoph U. Brand Switzerland 13 335 0.4× 289 0.9× 264 1.7× 31 0.3× 64 0.7× 24 736
J Sloan-Lancaster United States 8 733 0.9× 150 0.4× 66 0.4× 40 0.3× 65 0.7× 9 971
Barbara Metzler Switzerland 14 656 0.8× 137 0.4× 31 0.2× 82 0.7× 95 1.0× 19 978
M. Numasaki Japan 3 518 0.6× 342 1.0× 51 0.3× 36 0.3× 31 0.3× 5 695
Samik Basu United States 11 613 0.7× 259 0.8× 41 0.3× 73 0.6× 24 0.2× 15 909
Bijia Deng United States 12 534 0.6× 227 0.7× 25 0.2× 50 0.4× 75 0.8× 19 915
Marie‐Laure Boulland France 12 398 0.5× 306 0.9× 97 0.6× 25 0.2× 82 0.8× 20 866

Countries citing papers authored by Dorthe Lundsgaard

Since Specialization
Citations

This map shows the geographic impact of Dorthe Lundsgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorthe Lundsgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorthe Lundsgaard more than expected).

Fields of papers citing papers by Dorthe Lundsgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorthe Lundsgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorthe Lundsgaard. The network helps show where Dorthe Lundsgaard may publish in the future.

Co-authorship network of co-authors of Dorthe Lundsgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Dorthe Lundsgaard. A scholar is included among the top collaborators of Dorthe Lundsgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorthe Lundsgaard. Dorthe Lundsgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holm, Thomas Lindebo, Ditte Tornehave, Henrik Søndergaard, et al.. (2018). Evaluating IL-21 as a Potential Therapeutic Target in Crohn’s Disease. Gastroenterology Research and Practice. 2018. 1–22. 21 indexed citations
2.
Serikawa, Kyle, Søren Jacobsen, Dorthe Lundsgaard, et al.. (2013). Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients. Modern Rheumatology. 23(4). 729–740. 4 indexed citations
3.
Serikawa, Kyle, Søren Jacobsen, Dorthe Lundsgaard, et al.. (2012). Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients. Modern Rheumatology. 23(4). 729–740. 6 indexed citations
4.
Hummelshøj, Lone, Dorthe Lundsgaard, Lars Hornum, et al.. (2012). Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients. Lupus. 21(10). 1098–1104. 31 indexed citations
5.
Davis, Ian D., Richard Kefford, Michael Millward, et al.. (2009). Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial. Clinical Cancer Research. 15(6). 2123–2129. 120 indexed citations
6.
Johansen, Claus, P.A. Usher, Rasmus Boye Kjellerup, et al.. (2009). Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. British Journal of Dermatology. 160(2). 319–324. 266 indexed citations
7.
Frederiksen, Klaus Stensgaard, Dorthe Lundsgaard, Jeremy A. Freeman, et al.. (2008). IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma. Cancer Immunology Immunotherapy. 57(10). 1439–1449. 85 indexed citations
8.
Dodds, Michael, Klaus Stensgaard Frederiksen, Kresten Skak, et al.. (2008). Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteins. Cancer Immunology Immunotherapy. 58(6). 843–854. 21 indexed citations
9.
Davis, Ian D., Birte K. Skrumsager, Jonathan Cebon, et al.. (2007). An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma. Clinical Cancer Research. 13(12). 3630–3636. 132 indexed citations
10.
Skak, Kresten, Klaus Stensgaard Frederiksen, & Dorthe Lundsgaard. (2007). Interleukin‐21 activates human natural killer cells and modulates their surface receptor expression. Immunology. 123(4). 575–583. 120 indexed citations
11.
Hornum, Lars, Dorthe Lundsgaard, & Helle Markholst. (2007). PolyI:C Induction of Diabetes Is Controlled by Iddm4 in Rats with a Full Regulatory T Cell Pool. Annals of the New York Academy of Sciences. 1110(1). 65–72. 3 indexed citations
12.
Kjellev, Stine, Claus Haase, Dorthe Lundsgaard, et al.. (2007). Inhibition of NKG2D receptor function by antibody therapy attenuates transfer‐induced colitis in SCID mice. European Journal of Immunology. 37(5). 1397–1406. 39 indexed citations
13.
Nielsen, Henriette Svarre, et al.. (2007). Flow sorting from organ material by intracellular markers. Cytometry Part A. 71A(7). 495–500. 9 indexed citations
14.
Kjellev, Stine, Dorthe Lundsgaard, Steen Seier Poulsen, & Helle Markholst. (2006). Reconstitution of Scid mice with CD4+CD25− T cells leads to rapid colitis: An improved model for pharmacologic testing. International Immunopharmacology. 6(8). 1341–1354. 39 indexed citations
15.
Holm, Thomas Lindebo, Dorthe Lundsgaard, & Helle Markholst. (2006). Characteristics of Rat CD4+CD25+ T Cells and Their Ability to Prevent Not Only Diabetes But Also Insulitis in an Adoptive Transfer Model in BB Rats. Scandinavian Journal of Immunology. 64(1). 17–29. 8 indexed citations
16.
Gad, Monika, Dorthe Lundsgaard, Stine Kjellev, et al.. (2006). Reactivity of naive CD4+CD25− T cells against gut microflora in healthy mice. International Immunology. 18(5). 817–825. 8 indexed citations
17.
Lundsgaard, Dorthe, et al.. (2006). Sa.54. Interleukin-21: Intravenous Administration of Interleukin-21 Leads to Immune Activation in Humans-Preliminary Results from a Phase 1 Trial. Clinical Immunology. 119. S124–S124. 1 indexed citations
18.
Lundsgaard, Dorthe, Thomas Lindebo Holm, Lars Hornum, & Helle Markholst. (2005). In Vivo Control of Diabetogenic T-Cells by Regulatory CD4+CD25+ T-Cells ExpressingFoxp3. Diabetes. 54(4). 1040–1047. 46 indexed citations
19.
Lundsgaard, Dorthe & Helle Markholst. (2003). A co-transfer system in young prediabetic BB rats: reactivated autoreactive T cells can be partly controlled. Journal of Autoimmunity. 21(4). 325–338. 4 indexed citations
20.
Hornum, Lars, Dorthe Lundsgaard, & Helle Markholst. (2001). An F344 rat congenic for BB/DP rat-derived diabetes susceptibility loci Iddm1 and Iddm2. Mammalian Genome. 12(11). 867–868. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kresten Skak Breakdown of academic impact, for papers by Gabriella Rodolico Breakdown of academic impact, for papers by Kamruz Darabi Breakdown of academic impact, for papers by Christoph U. Brand Breakdown of academic impact, for papers by J Sloan-Lancaster Breakdown of academic impact, for papers by Barbara Metzler Breakdown of academic impact, for papers by M. Numasaki Breakdown of academic impact, for papers by Samik Basu Breakdown of academic impact, for papers by Bijia Deng Breakdown of academic impact, for papers by Marie‐Laure Boulland
Rankless by CCL
2026